Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

CTMX CytomX Therapeutics Inc

1,025

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 11:28:04

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

CytomX Therapeutics (NASDAQ:CTMX)
Historical Stock Chart
Von Dez 2024 bis Dez 2024

Click Here for more CytomX Therapeutics Charts.

CytomX Therapeutics (NASDAQ:CTMX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more CytomX Therapeutics Charts.

News CytomX Therapeutics Inc

CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
Mittwoch 27 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Donnerstag 7 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024
Donnerstag 31 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors
Montag 9 September 2024 (4 Monate vor) • GlobeNewswire Inc.

CytomX Therapeutics to Present at Upcoming September Investor Conferences
Mittwoch 4 September 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 23 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 23 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 22 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 22 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere CytomX Therapeutics Inc News-Artikel

Societe Generale Effekten

VanEck BDC Income ETF

JPX Global (CE)

Mueller Water Products

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen